Nathalie Augé

Nathalie Augé

Auto-generated profile, based on publicly available information

Nathalie Augé

INSERM U858, CHU Rangueil, Toulouse, France

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2010 in Free Radical Research
Verified
Journal Article
Closed access
PDF file
Anne Negre-SalvayreAnne Negre-Salvayre
Anne Negre-Salvayre
NANathalie Auge
Nathalie Auge
VAVictoria Ayala
Victoria Ayala
HBHuveyda Basaga
Huveyda Basaga
JBJordi Boada
Jordi Boada
Neven ZarkovicNeven Zarkovic
Neven Zarkovic
Lipid peroxidation (LPO) product accumulation in human tissues is a major cause of tissular and cellular dysfunction that plays a major role in ageing and most age-related and oxidative stress-related diseases. The current evidence for the implication of LPO in pathological processes is discussed in this review. New data and literature review are provided evaluating the role of LPO in the pathophysiology of ageing and classically oxidative stress-linked diseases, such as neurodegenerative diseases, diabetes and atherosclerosis (the main cause of cardiovascular complications). Striking evidences implicating LPO in foetal vascular dysfunction occurring in pre-eclampsia, in renal and liver diseases, as well as their role as cause and consequence to cancer development are addressed.

1 December 2009 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
Anne Negre-SalvayreAnne Negre-Salvayre
Anne Negre-Salvayre
RSRobert Salvayre
Robert Salvayre
NANathalie Augé
Nathalie Augé
RPReinald Pamplona
Reinald Pamplona
MPManuel Portero-Otín
Manuel Portero-Otín
Diabetes mellitus is a multifactorial disease, classically influenced by genetic determinants of individual susceptibility and by environmental accelerating factors, such as lifestyle. It is considered a major health concern,as its incidence is increasing at an alarming rate, and the high invalidating effects of its long-term complications affect macro- and microvasculature, heart, kidney, eye, and nerves. Increasing evidence indicates that hyperglycemia is the initiating cause of the tissue damage occurring in diabetes, either through repeated acute changes in cellular glucose metabolism, or through the long-term accumulation of glycated biomolecules and advanced glycation end products (AGEs). AGEs represent a heterogeneous group of chemical products resulting from a nonenzymatic reaction between reducing sugars and proteins, lipids, nucleic acids, or a combination of these.The glycation process (glucose fixation) affects circulating proteins (serum albumin, lipoprotein, insulin, hemoglobin),whereas the formation of AGEs implicates reactive intermediates such as methylglyoxal. AGEs form cross-links on long-lived extracellular matrix proteins or react with their specific receptor RAGE, resulting inoxidative stress and proinflammatory signaling implicated in endothelium dysfunction, arterial stiffening, and microvascular complications. This review summarizes the mechanism of glycation and of AGEs formation and the role of hyperglycemia, AGEs, and oxidative stress in the pathophysiology of diabetic complications.

1 December 2002 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
RSRobert Salvayre
Robert Salvayre
NANathalie Auge
Nathalie Auge
HBHerve Benoist
Herve Benoist
Anne Negre-SalvayreAnne Negre-Salvayre
Anne Negre-Salvayre

9 July 2009 in Stem Cells
Verified
Journal Article
Open access
PDF file
CMCéline Mias
Céline Mias
OLOlivier Lairez
Olivier Lairez
ETElodie Trouche
Elodie Trouche
JRJérome Roncalli
Jérome Roncalli
DCDenis Calise
Denis Calise
DCDaniel Cussac
Daniel Cussac
Recent studies showed that mesenchymal stem cells (MSCs) transplantation significantly decreased cardiac fibrosis; however, the mechanisms involved in these effects are still poorly understood. In this work, we investigated whether the antifibrotic properties of MSCs involve the regulation of matrix metalloproteinases (MMPs) and matrix metalloproteinase endogenous inhibitor (TIMP) production by cardiac fibroblasts. In vitro experiments showed that conditioned medium from MSCs decreased viability, α-smooth muscle actin expression, and collagen secretion of cardiac fibroblasts. These effects were concomitant with the stimulation of MMP-2/MMP-9 activities and membrane type 1 MMP expression. Experiments performed with fibroblasts from MMP2-knockout mice demonstrated that MMP-2 plays a preponderant role in preventing collagen accumulation upon incubation with conditioned medium from MSCs. We found that MSC-conditioned medium also decreased the expression of TIMP2 in cardiac fibroblasts. In vivo studies showed that intracardiac injection of MSCs in a rat model of postischemic heart failure induced a significant decrease in ventricular fibrosis. This effect was associated with the improvement of morphological and functional cardiac parameters. In conclusion, we showed that MSCs modulate the phenotype of cardiac fibroblasts and their ability to degrade extracellular matrix. These properties of MSCs open new perspectives for understanding the mechanisms of action of MSCs and anticipate their potential therapeutic or side effects. Disclosure of potential conflicts of interest is found at the end of this article.

13 February 2009 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MSMarie Sanson
Marie Sanson
NANathalie Augé
Nathalie Augé
Cecile VindisCecile Vindis
Cecile Vindis
CMCarole Muller
Carole Muller
YBYoshio Bando
Yoshio Bando
Anne Negre-SalvayreAnne Negre-Salvayre
Anne Negre-Salvayre
Oxidized low-density lipoproteins (oxLDLs) trigger various biological responses potentially involved in atherogenesis. Disturbing endoplasmic reticulum (ER) function results in ER stress and unfolded protein response, which tends to restore ER homeostasis but switches to apoptosis when ER stress is prolonged. We aimed to investigate whether ER stress is induced by oxLDLs and can be prevented by the ER-associated chaperone ORP150 (150-kDa oxygen-regulated protein). oxLDLs and the lipid oxidation products 7-ketocholesterol and 4-hydroxynonenal induce ER stress in human endothelial cells (HMEC-1), characterized by the activation of ER stress sensors (phosphorylation of Ire1α and PERK, nuclear translocation of ATF6) and of their subsequent pathways (eukaryotic initiation factor 2α phosphorylation, expression of XBP1/spliced XBP1, CHOP, and KDEL chaperones GRP78, GRP94, ORP150). ER stress was inhibited by the antioxidant N -acetylcysteine. In advanced atherosclerotic lesions, phospho-Ire1α, KDEL, and ORP150 staining were localized in lipid-rich areas with 4-hydroxynonenal adducts and CD68-positive macrophagic cells. By comparison, staining for 4-hydroxynonenal, phospho-Ire1α, KDEL, and ORP were faint and more diffuse in intimal hyperplasia. ER stress takes part in the apoptotic effect of oxLDLs, through the Ire1α/c-Jun N-terminal kinase pathway, as assessed by the protective effect of specific small interfering RNAs and c-Jun N-terminal kinase inhibitor. Forced expression of the chaperone ORP150 reduced both oxLDL-induced ER stress and apoptosis. ER stress markers and ORP150 chaperone are expressed in areas containing oxLDLs in atherosclerotic lesions and are induced by oxLDLs and oxidized lipids in cultured cells. The forced expression of ORP150 highlights its new protective role against oxLDL-induced ER stress and subsequent apoptosis.

17 July 2005 in Nature Genetics
Verified
Journal Article
Closed access
IAIsabelle Aubin
Isabelle Aubin
CACarolyn P Adams
Carolyn P Adams
SOSibylle Opsahl
Sibylle Opsahl
DSDominique Septier
Dominique Septier
CBColin E Bishop
Colin E Bishop
CPChristophe Poirier
Christophe Poirier